Male contraception - A topic with many facets

Molecular and Cellular Endocrinology

Volumn 216, Issue 1-2, 2004, Pages 75-82

  Lye, R John ^a   Sipilä, Petra ^b   Vernet, Patrick ^c   Wagenfeld, Andrea ^d  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d BAYER PHARMA AG   (Germany)

Author keywords

Acquired immunodeficiency syndrome; AIDS; CI; Coitus interruptus; Follicle stimulating hormone; FSH; GnRH; Gonadotrophin releasing hormone; HIV; Human immonodeficiency virus; Intrauterine device; IUD; LH; Luteinizing hormone; PA; Periodic abstinence; STD

Indexed keywords

CONTRACEPTIVE AGENT; GESTAGEN; TESTOSTERONE;

CONDOM; CONTRACEPTION; CULTURAL ANTHROPOLOGY; ETHNOLOGY; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SOCIAL ADAPTATION; SURGICAL TECHNIQUE;

EID: 1942436353     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.10.071     Document Type: Article

References (45)

1. Badran H.H., Hermo L.S. Expression and regulation of aquaporins 1, 8, and 9 in the testis, efferent ducts, and epididymis of adult rats and during postnatal development. J. Androl. 23:2002;358-373.
2. Bardhan J., Ria S.S., Sawhney R.C., Kain A.K., Thomas P., Ilavazhagan G. Neem oil - a fertility controlling agent in rhesus monkey. Indian J. Physiol. Pharmacol. 35:1991;278-280.
3. Bart J., Groen H.J., van der Graaf W.T., Hollema H., Hendrikse N.H., Vaalburg W., Sleijfer D.T., de Vries E.G. An oncological view on the blood-testis barrier. Lancet Oncol. 3:2002;357-363.
4. Breton S., Hammar K., Smith P.J., Brown D. Proton secretion in the male reproductive tract: involvement of Cl-independent HCO-3 transport. Am. J. Physiol. 275:1998;1134-1142.
5. Chen, Z.W., Gu, Y.Q., Liang, X.W., Wu, Z.G., Yin, E.J., Li-Hong, 1992. Safety and efficacy of percutaneous injection of polyurethane elastomer (MPU) plugs for vas occlusion in man. Int. J. Androl. 15, 468-472.
6. Chen Z.W., Gu Y.Q., Liang X.W., Shen L.J., Zou W.Z. Morphological observations of vas deferens occlusion by the percutaneous injection of medical polyurethane. Contraception. 53:1996;275-279.
7. Cheng C.Y., Mo M., Grima J., Saso L., Tita B., Mruk D., Silvestrini B. Indazole carboxylic acids in male contraception. Contraception. 65:2002;265-268.
8. Cheng C.Y., Mruk D.D. Cell junction dynamics in the testis: Sertoli-germ cell interactions and male contraceptive development. Physiol. Rev. 82:2002;825-874.
9. Cooper T.G. Interactions between epididymal secretions and spermatozoa. J. Reprod. Fertil. S53:1998;119-136.
10. Coutinho E.M., Athayde C., Atta G., Gu Z.P., Chen Z.W., Sang G.W., Emuveyan E., Adekunle A.O., Mati J., Otubu J., Reidenberg M.M., Segal S.J. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive, a multicenter, international, dose-finding study. Contraception. 61:2000;61-67.
11. Cuasnicu P.S., Ellerman D.A., Cohen D.J., Busso D., Morgenfeld M.M., Da Ros V.G. Molecular mechanisms involved in mammalian gamete fusion. Arch. Med. Res. 32:2001;614-618.
12. Drennam, M., 1998. Reproductive health: new perspectives on men's participation. Popul. Rep., Ser. J. 46.
13. Fraser L.R. Sperm capacitation and the acrosome reaction. Hum. Reprod. 13:1998;9-19.
14. Frayne J., Hall L. The potential use of sperm antigens as targets for immunocontraception, past, present and future. J. Reprod. Immunol. 43:1999;1-33.
15. Fu H., Darroch J.E., Haas T., Ranjit N. Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth. Fam. Plann. Perspect. 31:1999;56-63.
16. Glasier A.F., Anakwe R., Everington D., Martin C.W., van der Spuy Z., Cheng L., Ho P.C., Anderson R.A. Would women trust their partners to use a male pill? Hum. Reprod. 15:2000;646-649.
17. Guha S.K. Non-invasive reversal of intraluminal vas deferens polymer injection induced azoospermia-technology. Asian J. Androl. 1:1999;131-134.
18. Henshaw S.K. Unintended pregnancy in the United-States. Fam. Plann. Perspect. 30:1998;24-29.
19. Hikim A.P., Lue Y.H., Wang C., Reutrakul V., Sangsuwan R., Swerdloff R.S. Posttesticular antifertility action of triptolide in the male rat: evidence for severe impairment of cauda epididymal sperm ultrastructure. J. Androl. 21:2000;431-437.
20. Hinton B.T., Lan Z.J., Rudolph D.B., Labus J.C., Lye R.J. Testicular regulation of epididymal gene expression. J. Reprod. Fertil. S53:1998;47-57.
21. Huynh P.N., Hikim A.P., Wang C., Stefonovic K., Lue Y.H., Leung A., Atienza V., Baravarian S., Reutrakul V., Swerdloff R.S. Long-term effects of triptolide on spermatogenesis, epididymal sperm function, and fertility in male rats. J. Androl. 21:2000;689-699.
22. Jensen J.T. Male contraception. Curr. Womens Health Rep. 2:2002;338-345.
23. Kamischke A., Heuermann T., Kruger K., von Eckardstein S., Schellschmidt I., Rubig A., Nieschlag E. An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations. J. Clin. Endocrinol. Metab. 87:2002;530-539.
24. + exchanger isoform, NHE-3, is present in the rat epididymal epithelium. Pflugers Arch. 442:2001;230-236.
25. Krishnamurthy H., Danilovich N., Morales C.R., Sairam M.R. Qualitative and quantitative decline in spermatogenesis of the follicle-stimulating hormone receptor knockout (FORKO) mouse. Biol. Reprod. 62:2000;1146-1159.
26. Ladd A., Tsong Y.Y., Lok J., Thau R.B. Active immunization against LHRH. I. Effects of conjugation site and dose. Am. J. Reprod. 22:1990;56-63.
27. Liu, Z.Q., Liu, G.Z., Hei, L.S., Zhang, R.A., Yu, C.Z., 1981. Clinical trial of gossypol as a male antifertility agent. In: Chang, C.F., Griffin, P.D., Woolman, A. (Eds.), Recent Advances in Fertility Regulation. Atar, SA, Geneva, pp. 160-163.
28. Lohiya N.K., Manivannan B., Mishra P.K., Pathak N. Vas deferens, a site of male contraception: an overview. Asian J. Androl. 3:2001;87-95.
29. Martin C.W., Anderson R.A., Cheng L., Ho P.C., van der Spuy Z., Smith K.B., Glasier A.F., Everington D., Baird D.T. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum. Reprod. 15:2000;637-645.
30. Mazumdar S., Levine A.S. Antisperm antibodies: etiology, pathogenesis, diagnosis, and treatment. Fertil. Steril. 70:1998;799-810.
31. Meriggiola M.C., Bremner W.J., Costantino A., Di Cintio G., Flamigni C. Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Hum. Reprod. 13:1998;1225-1229.
32. Mulryan K., Gitterman D.P., Lewis C.J., Vial C., Leckie B.J., Cobb A.L., Brown J.E., Conley E.C., Buell G., Pritchard C.A., Evans R.J. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature. 403:2000;86-89.
33. Qian S.Z. Gossypol-hypokalaemia interrelationships. Int. J. Androl. 8:1985;313-324.
34. Rao A.J. Is there a role for contraceptive vaccines in fertility control. J. Biosci. 26:2001;425-427.
35. Ross, J., Hardee, K., Mumford, E., Eid, S., 2000. Contraceptive method choice in developing countries. Int. Fam. Plann. Perspect. 28(1).
36. Sethi N., Srivastava R.K., Singh R.K., Bhatia G.S., Sinha N. Chronic toxicity of styrene maleic anhydride, a male contraceptive, in rhesus monkeys (Macaca mulatta). Contraception. 42:1990;337-347.
37. Sonnenberg-Riethmacher E., Walter B., Riethmacher D., Godecke S., Birchmeier C. The c-ros tyrosine kinase receptor controls regionalization and differentiation of epithelial cells in the epididymis. Genes Dev. 10:1996;1184-1193.
38. Tulsiani D.R., Orgebin-Crist M.C., Skudlarek M.D. Role of luminal fluid glycosyltransferases and glycosidases in the modification of rat sperm plasma membrane glycoproteins during epididymal maturation. J. Reprod. Fertil. Suppl. 53:1998;85-97.
39. van der Spoel A.C., Jeyakumar M., Butters T.D., Charlton H.M., Moore H.D., Dwek R.A., Platt F.M. Reversible infertility in male mice after oral administration of alkylated imino sugars: a nonhormonal approach to male contraception. Proc. Natl. Acad. Sci. U.S.A. 99:2002;17173-17178.
40. United Nations Population Division, 1998. Levels and Trends of Contraceptive Use as Assessed in 1998.
41. Upadhyay S.N., Dhawan S., Talwar G.P. Antifertility effects of neem (Azadirachta indica) oil in male rats by single intra-vas administration: an alternate approach to vasectomy. J. Androl. 14:1993;275-281.
42. Waites G.M., Wang C., Griffin P.D. Gossypol: reasons for its failure to be accepted as a safe, reversible male antifertility drug. Int. J. Androl. 21:1998;8-12.
43. Wu F.C., Balasubramanian R., Mulders T.M., Coelingh-Bennink H.J. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J. Clin. Endocrinol. Metab. 84:1999;112-122.
44. Yeung C.H., Sonnenberg-Riethmacher E., Cooper T.G. Infertile spermatozoa of c-ros tyrosine kinase receptor knockout mice show flagellar angulation and maturational defects in cell volume regulatory mechanisms. Biol. Reprod. 61:1999;1062-1069.
45. Yeung C.H., Perez-Sanchez F., Schroter S., Kirchhoff C., Cooper T.G. Changes of the major sperm maturation-associated epididymal protein HE5 (CD52) on human ejaculated spermatozoa during incubation. Mol. Hum. Reprod. 7:2001;617-624.